Composition for external use

US2019343796A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2019343796-A1
Application numberUS-201716474405-A
CountryUS
Kind codeA1
Filing dateDec 28, 2017
Priority dateDec 28, 2016
Publication dateNov 14, 2019
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

An object of the present invention is to provide a composition for external use having an improved skin permeability of 1-(3-(2-(1-benzothiophen-5-yl)ethoxy)propyl)azetidin-3-ol or a salt thereof. The present invention provides a composition for external use comprising 1-(3-(2-(1-benzothiophen-5-yl)ethoxy)propyl)azetidin-3-ol or a salt thereof, one or more solvents selected from the group consisting of alcohols, sulfoxides and amides, and a permeation enhancer.

First claim

Opening claim text (preview).

1 - 13 . (canceled) 14 . A composition for external use comprising 1-(3-(2-(1-benzothiophen-5-yl)ethoxy)propyl)azetidin-3-ol or a salt thereof, one or more solvents selected from the group consisting of alcohols, sulfoxides and amides, and a permeation enhancer. 15 . The composition for external use according to claim 14 , wherein the solvent is selected from the group consisting of ethanol, benzyl alcohol, propylene glycol, butylene glycol, dipropylene glycol, polyethylene glycol, dimethyl sulfoxide and N-methyl-2-pyrrolidone. 16 . The composition for external use according to claim 14 , further comprising water. 17 . The composition for external use according to claim 14 , wherein the permeation enhancer is a compound having a carboxyl group, a hydroxyl group or an alkoxycarbonyl group. 18 . The composition for external use according to claim 14 , wherein the permeation enhancer is a compound having an aliphatic group having 5 to 18 carbon atoms. 19 . The composition for external use according to claim 14 , further comprising a water-soluble polymer. 20 . The composition for external use according to claim 19 , wherein the water-soluble polymer is selected from the group consisting of carrageenan, propylene glycol alginate, agar, gelatin, hydroxypropyl cellulose, polyvinyl pyrrolidone, carboxyvinyl polymer, sodium polyacrylate and polyvinyl alcohol. 21 . The composition for external use according to claim 19 , wherein the water-soluble polymer is selected from the group consisting of propylene glycol alginate, agar, gelatin, hydroxypropyl cellulose and polyvinyl pyrrolidone. 22 . The composition for external use according to claim 14 , further comprising an adhesive agent. 23 . The composition for external use according to claim 14 , wherein the composition is a transdermal composition for external use. 24 . An adhesive preparation comprising the composition for external use according to claim 14 . 25 . The adhesive preparation according to claim 24 , wherein the adhesive preparation is a cataplasm or a patch. 26 . The composition for external use according to claim 14 , wherein the composition is a transnasal composition for external use.

Assignees

Inventors

Classifications

  • Ointments; Bases therefor; {Other semi-solid forms, e.g. creams, sticks, gels (composition of ointments, creams or gels A61K47/00)} · CPC title

  • Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein (oligopeptides having up to five amino acids {A61K47/183}; polyamino acids A61K47/34) · CPC title

  • A61K31/397Primary

    having four-membered rings, e.g. azetidine · CPC title

  • Skin, i.e. galenical aspects of topical compositions (non-active ingredients are additionally classified in A61K47/00; A61K9/0009, A61K9/0021, A61K9/7015, A61K9/7023 take precedence; cosmetic preparations A61K8/00, A61Q; preparations for wound dressings or bandages A61L26/00) · CPC title

  • Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers {, poly(meth)acrylates, or polyvinyl pyrrolidone} · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2019343796A1 cover?
An object of the present invention is to provide a composition for external use having an improved skin permeability of 1-(3-(2-(1-benzothiophen-5-yl)ethoxy)propyl)azetidin-3-ol or a salt thereof. The present invention provides a composition for external use comprising 1-(3-(2-(1-benzothiophen-5-yl)ethoxy)propyl)azetidin-3-ol or a salt thereof, one or more solvents selected from the group consi…
Who is the assignee on this patent?
Fujifilm Toyama Chemical Co Ltd
What technology area does this patent fall under?
Primary CPC classification A61K31/397. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Thu Nov 14 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).